The evolution of nocturnal polyuria and saluresis in renal allograft recipients was studied by comparing the day to night (D:N) ratios of urine volume and sodium excretion in 15 patients who had undergone transplantation less than one year previously (recent-transplant group) with those in 11 patients who had undergone transplantation at least one year previously. Eleven patients with chronic renal failure and 12 normal subjects served as controls. Patients in the recent-transplant group had significantly lower D:N ratios of urine volume and sodium excretion than the patients who had undergone transplantation at least a year before, while the ratios in this last group did not differ significantly from those in the normal subjects. Nocturnal polyuria and saluresis gradually subsided in five patients studied for three months.
Introduction
Complaints of nocturnal polyuria by renal allograft recipients prompted us to conduct a study investigating the cause of this phenomenon.
Subjects, methods, and results
We studied 15 patients who had undergone transplantation fairly recently-that is, from the time their plasma creatinine concentration stabilised to about 10 months after operation-and 11 patients at least one year after transplantation. Eleven patients with chronic renal
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Hospital, London NW3 2QG M K CHAN, Ma, MRCP, registrar (now research fellow) Z VARGHESE, MSC, PHD, principal biochemist 0 N FERNANDO, FRCS, FRCSED, consultant surgeon J F MOORHEAD, MB, FRCP, director failure and 12 normal subjects served as control groups. No patients were taking diuretics or beta-blockers. Urine was collected 12-hourly, from 0800 to 2000 (day collection) and from 2000 to 0800 (night collection). Aliquots from each sample were taken for measurement of creatinine, sodium, and potassium concentrations. Blood was taken for estimation of the plasma creatinine concentration, and the day and night creatinine clearances were estimated from the same plasma sample. Patients in the recent-transplant group were studied for three months, the frequency of sampling varying from thrice weekly to once monthly. The patients entered the study at different times after transplantation. The remaining patients and the controls were studied for at least three consecutive days. 
Results
Results were expressed as mean ratios of the day to night (D:N) values (table). The figure shows the D :N ratios of urine volume in five patients studied at regular one-to two-weekly intervals for over 10 weeks. The Valsalva ratio' was determined to assess autonomic function in eight patients in the recent-transplant group and in 42 healthy volunteers. The difference between the two groups was not significant (mean±SE of mean ratio 1 62±0 11 (patients) and 1-8± 0 33 (volunteers); Student's t test).
Discussion
Our study confirmed that nocturnal polyuria was common up to 10 months after transplantation and that it disappeared in patients studied at least a year after operation (see figure) . We did not study the diurnal rhythm of water and salt excretion in Mean (± SE of mean) day to night (D:N) ratios of urine volume, sodium and potassium excretions, and creatinine clearance and 24-hour creatinine clearance in patients studied up to 10 months after transplantation (recent-transplant group) and those studied at least a year after transplantation, patients with chronic renal failure, and normal controls Creatinine clearance. Postural influence-The reported normal diurnal rhythm of water excretion in renal allograft recipients when the influence of posture has been eliminatedf6 suggests that the denervated kidney is unduly sensitive to postural changes. This is supported by our observation that when the patient in case 1 remained recumbent for 24 hours the nocturia was almost completely abolished (D :N urine-volume ratio changed from 035 to 090) while the dose of immunosuppressive drugs remained unaltered. It is not known why this supersensitivity to postural changes disappeared at least a year after transplantation, although gradual adaptation of the denervated vasculature is possible. Whether or not re-enervation of the graft7 plays a part remains speculative.
Our study has shown that renal allograft recipients often have nocturia, which abates spontaneously, usually within a year after operation. It is not due to renal insufficiency, autonomic neuropathy, or immunosuppressive drugs but is related to postural influences. Patients who have received transplants and who complain of nocturia should be reassured that it will eventually disappear.
Cimetidine is a potent histamine H2-receptor antagonist that has proved useful in digestive disorders with gastric-acid hypersecretion.' It has been used for pruritus related to cholestasis,2 chronic renal failure,3 and myeloproliferative disorders.4 These reports have prompted us to try the drug in four cases of pruritus due to Hodgkin's disease.
Case reports
(1) A 24-year-old woman was admitted because of low back pain, weight loss, night sweats, and intense generalised pruritus. Biopsy of a left supraclavicular lymph node showed Hodgkin's disease, nodular sclerosis type. Staging laparotomy was not performed because of lymphographic abnormalities of the retroperitoneal nodes. Cimetidine by mouth was started at a dose of 1 g daily (200 mg at mealtimes three times a day, and 400 mg at bedtime). The pruritus completely disappeared within 24 hours. The itching returned within 12 hours when cimetidine was stopped and disappeared when it was restarted. Cimetidine was withdrawn when chemotherapy (MOPP regimen) was begun. Pruritus did not recur.
(2) A 19-year-old woman was referred to us because of enlarged cervical and mediastinal lymph nodes and a three-month history of lassitude, sweats, and generalised pruritus. Biopsy of a cervical node showed lymphocytedepleted Hodgkin's disease. She was given cimetidine 1 g daily by mouth (200 mg at mealtimes and 400 mg at bedtime). This dramatically reduced itching and sweats within one day. Pruritus and sweats returned within 12 hours when cimetidine was withdrawn.
(3) A 29-year-old woman with a six-month history of severe pruritus and night sweats was admitted with cervical and mediastinal lymphadenopathy. Biopsy of a cervical node showed nodular sclerosing Hodgkin's disease. We tried dexchlorpheniramine for the itching effect. Cimetidine by mouth 1 g daily (200 mg at mealtimes and 400 mg at bedtime) was given. Relief from the pruritus and sweats was progressive and complete within four days. Cimetidine was stopped, without any recurrence of itching, when the patient began a MOPP regimen.
(4) A 22-year-old woman was admitted for fever, sweats, pruritus, and cervical, axillary, and inguinal lymphadenopathy. Biopsy of an inguinal lymph node showed nodular sclerosing Hodgkin's disease. Four cycles of MOPP were given. Pruritus and fever reappeared soon after the fourth course of MOPP. Cimetidine 1 g daily by mouth (200 mg at mealtimes and 400 mg at bedtime) was started. Within four days her pruritus was completely relieved. Cimetidine was discontinued without immediate recurrence of itching. It was successfully resumed 10 days later for a recurrence of itching.
Comment
Severe generalised pruritus is not uncommon in Hodgkin's disease. Its pathogenesis is poorly understood, and treatment with systemic or topical medications is often disappointing. Itching was relieved in all our patients by cimetidine alone-within a day in two cases and after a few days in the other two. When treatment was stopped itching
